lobbying_activities: 2680824

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2680824	1618e4ae-b6dc-444e-b440-b275ab5e124a	Q3	MCDERMOTT WILL & SCHULTE LLP	24338	SURESCRIPTS	2021	third_quarter	SCI	Efforts to advance interoperability and to ensure that technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services sector in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for more expeditious adoption of updated electronic prescribing standards. Efforts to ensure timely implementation of the SUPPORT Act requirement for electronic prescribing of controlled substances (EPCS) in the Medicare Part D program and to encourage CMS to expand the use of EPCS beyond the Part D program. Efforts to support CMS rulemaking to ensure timely advancement of the NCPDP Formulary and Benefit Standard from Version 3.0 to Version 5.0 and to ensure timely adoption of a Real-Time Benefit Tool standard as soon as one is approved by NCPDP. Efforts to obtain clarity relating to the HIPAA Transactions Rule and Code Sets Rule to ensure that the eligibility transaction requirements do not apply to prior authorization requests for prescription drugs so that electronic prior authorization by non-Part D prescribers using the NPCPD SCRIPT Standard Version 2017071 is not impeded.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES	40000		0	0	2021-10-14T17:47:22.033000-04:00